TSPO and neoplasm: We validated TSPO-mediated protection against cytotoxic molecules in the T cell supernatants by cytotoxicity assays, where TSPO-deficient BTIC13 clones and BTIC129 cells exerted increased apoptosis upon treatment with activated supernatant compared to TSPO-proficient tumor cells (Fig. 4e, f).